DK1383733T3 - Fremgangsmåde til fremstilling af 1,3-substituerede indener og aryl-sammenföjede azapolycykliske forbindelser - Google Patents
Fremgangsmåde til fremstilling af 1,3-substituerede indener og aryl-sammenföjede azapolycykliske forbindelserInfo
- Publication number
- DK1383733T3 DK1383733T3 DK02701498T DK02701498T DK1383733T3 DK 1383733 T3 DK1383733 T3 DK 1383733T3 DK 02701498 T DK02701498 T DK 02701498T DK 02701498 T DK02701498 T DK 02701498T DK 1383733 T3 DK1383733 T3 DK 1383733T3
- Authority
- DK
- Denmark
- Prior art keywords
- aryl
- joined
- preparation
- azapolycyclic compounds
- domains
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C255/47—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of rings being part of condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28513101P | 2001-04-20 | 2001-04-20 | |
PCT/IB2002/000660 WO2002085843A2 (en) | 2001-04-20 | 2002-03-04 | Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1383733T3 true DK1383733T3 (da) | 2008-06-09 |
Family
ID=23092860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02701498T DK1383733T3 (da) | 2001-04-20 | 2002-03-04 | Fremgangsmåde til fremstilling af 1,3-substituerede indener og aryl-sammenföjede azapolycykliske forbindelser |
Country Status (25)
Country | Link |
---|---|
US (2) | US7091372B2 (es) |
EP (1) | EP1383733B1 (es) |
JP (1) | JP2004527545A (es) |
KR (1) | KR100551183B1 (es) |
CN (1) | CN1321107C (es) |
AR (2) | AR035957A1 (es) |
AT (1) | ATE388135T1 (es) |
AU (1) | AU2002234836B2 (es) |
BR (1) | BR0208992A (es) |
CA (1) | CA2443946A1 (es) |
CZ (1) | CZ20032814A3 (es) |
DE (1) | DE60225433T2 (es) |
DK (1) | DK1383733T3 (es) |
ES (1) | ES2300430T3 (es) |
HK (1) | HK1062170A1 (es) |
HU (1) | HUP0303811A3 (es) |
IL (1) | IL157881A0 (es) |
MX (1) | MXPA03009527A (es) |
PL (1) | PL366657A1 (es) |
PT (1) | PT1383733E (es) |
RU (1) | RU2282619C9 (es) |
TW (1) | TWI244472B (es) |
WO (1) | WO2002085843A2 (es) |
YU (1) | YU78303A (es) |
ZA (1) | ZA200307205B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003044877A2 (en) * | 2001-11-16 | 2003-05-30 | Cdt Oxford Limited | Light emitting device and compounds for use therein |
CN1714075A (zh) * | 2002-11-25 | 2005-12-28 | 辉瑞产品公司 | 1,3-取代的茚类的改进制备方法 |
KR20070087258A (ko) * | 2003-01-15 | 2007-08-27 | 화이자 프로덕츠 인크. | 아릴 융합된 폴리시클릭 락탐의 제조 방법 |
EP1638971B1 (en) * | 2003-06-04 | 2008-08-20 | Pfizer Products Inc. | Preparation of substituted quinoxalines from the dianiline with 2,3-dihydroxy-1,4-dioxane |
WO2005007630A2 (en) * | 2003-07-21 | 2005-01-27 | Pfizer Products Inc. | Aryl fused azapolycyclic compounds |
ES2343141T3 (es) * | 2005-11-16 | 2010-07-23 | F. Hoffmann-La Roche Ag | Nuevo procedimiento para la preparacion de thoc. |
DE102006024903A1 (de) * | 2006-05-24 | 2007-11-29 | Basf Ag | Verfahren zur Vermeidung von Fumarsäureablagerungen bei der Herstellung von Maleinsäureanhydrid |
ES2374337T3 (es) | 2007-05-16 | 2012-02-15 | Nycomed Gmbh | Derivados de pirazolona como inhibidores de pde4. |
EP2019107A1 (en) | 2007-07-26 | 2009-01-28 | Dynamit Nobel GmbH Explosivstoff- und Systemtechnik | Use of phosphonium salts in coupling reactions and process for their manufacture |
WO2009065872A2 (en) * | 2007-11-20 | 2009-05-28 | Medichem, S.A. | Improved processes for the synthesis of varenicline l-tartrate |
WO2009101185A2 (en) * | 2008-02-15 | 2009-08-20 | Medichem, S.A. | A NEW POLYMORPHIC FORM OF A PYRAZINO[2,3-h][3] BENZAZEPINE DERIVATIVE |
US8039620B2 (en) | 2008-05-22 | 2011-10-18 | Teva Pharmaceutical Industries Ltd. | Varenicline tosylate, an intermediate in the preparation process of varenicline L-tartrate |
US20090318695A1 (en) * | 2008-06-19 | 2009-12-24 | Vinod Kumar Kansal | Processes for the preparation of varenicline and intermediates thereof |
WO2010005643A1 (en) * | 2008-07-10 | 2010-01-14 | Teva Pharmaceutical Industries Ltd. | Processes for purifying varenicline l-tartrate salt and preparing crystalline forms of varenicline l-tartrate salt |
WO2010151524A1 (en) | 2009-06-22 | 2010-12-29 | Teva Pharmaceutical Industries Ltd | Solid states forms of varenicline salts and processes for preparation thereof |
US20120004239A1 (en) | 2010-06-11 | 2012-01-05 | Medichem, S.A. | Process for Preparing Quinoxaline Derivatives |
KR101603427B1 (ko) * | 2014-08-14 | 2016-03-15 | 영남대학교 산학협력단 | 케스케이드 반응을 통한 인덴 유도체의 효율적 합성방법 |
CN104478803A (zh) * | 2014-12-19 | 2015-04-01 | 连云港恒运医药科技有限公司 | 伐尼克兰中间体及其硝基还原杂质的制备方法 |
EP3334703A4 (en) * | 2015-08-14 | 2019-07-03 | Boulos & Cooper Pharmaceuticals PTY Ltd | SYNTHESIS OF ARYLIC COMPOUNDS |
CA3030147A1 (en) | 2016-07-07 | 2018-01-11 | Howard Hughes Medical Institute | Modified ligand-gated ion channels and methods of use |
US10961296B2 (en) * | 2017-11-10 | 2021-03-30 | Howard Hughes Medical Institute | Modified ligand-gated ion channels and methods of use |
CN111995519B (zh) * | 2020-09-26 | 2022-08-26 | 安徽金禾实业股份有限公司 | 一种3-甲氧基丙烯酸甲酯的制备方法 |
CN115322105A (zh) * | 2021-05-11 | 2022-11-11 | 江苏润安制药有限公司 | 一种合成艾拉莫德关键中间体的方法 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5479598A (en) * | 1992-10-23 | 1995-12-26 | International Business Machines Corporation | Compact graphical parallel program user output interface controlled directly by the parallel computer program |
DE69409445D1 (de) * | 1993-07-27 | 1998-05-14 | Ibm | Prozessüberwachung in einem Mehrfachverarbeitungsanbieter |
US6289368B1 (en) * | 1995-12-27 | 2001-09-11 | First Data Corporation | Method and apparatus for indicating the status of one or more computer processes |
US5928323A (en) * | 1996-05-30 | 1999-07-27 | Sun Microsystems, Inc. | Apparatus and method for dynamically generating information with server-side software objects |
FR2751448B1 (fr) * | 1996-07-17 | 1999-01-15 | Bull Sa | Procede de surveillance en temps reel d'un systeme informatique pour son administration et l'aide a sa maintenance en phase d'exploitation |
US6112194A (en) * | 1997-07-21 | 2000-08-29 | International Business Machines Corporation | Method, apparatus and computer program product for data mining having user feedback mechanism for monitoring performance of mining tasks |
US6119165A (en) * | 1997-11-17 | 2000-09-12 | Trend Micro, Inc. | Controlled distribution of application programs in a computer network |
US6100887A (en) * | 1997-12-05 | 2000-08-08 | At&T Corporation | Reusable reversible progress indicator software component for a graphical user interface |
DK1044189T4 (en) * | 1997-12-31 | 2015-03-30 | Pfizer Prod Inc | Aryl-fused fused azapolycyclic connections |
US6605610B1 (en) * | 1997-12-31 | 2003-08-12 | Pfizer Inc | Aryl fused azapolycyclic compounds |
US6151357A (en) * | 1998-01-16 | 2000-11-21 | Aspect Communications Corporation | Method and apparatus for displaying a visual indication of a transmission status |
US6108003A (en) * | 1998-03-18 | 2000-08-22 | International Business Machines Corporation | Maintaining visibility and status indication of docked applications and application bars |
CN1144787C (zh) * | 1998-04-29 | 2004-04-07 | 辉瑞产品公司 | 芳基稠合氮杂多元环化合物 |
FR2788982B1 (fr) * | 1999-02-02 | 2002-08-02 | Synthelabo | Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique |
AU5667100A (en) * | 1999-07-02 | 2001-01-22 | Prescient Neuropharma Inc. | Novel aminoindanes |
IL137937A0 (en) * | 1999-08-27 | 2001-10-31 | Pfizer Prod Inc | A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal |
US20010036943A1 (en) * | 2000-04-07 | 2001-11-01 | Coe Jotham W. | Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines |
US20010036949A1 (en) * | 2000-05-09 | 2001-11-01 | Coe Jotham Wadsworth | Pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal |
US20020010192A1 (en) * | 2000-06-02 | 2002-01-24 | Coe Jotham Wadsworth | Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |
US20020016334A1 (en) * | 2000-07-31 | 2002-02-07 | Coe Jotham Wadsworth | Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD) |
-
2002
- 2002-03-04 MX MXPA03009527A patent/MXPA03009527A/es active IP Right Grant
- 2002-03-04 CA CA002443946A patent/CA2443946A1/en not_active Abandoned
- 2002-03-04 ES ES02701498T patent/ES2300430T3/es not_active Expired - Lifetime
- 2002-03-04 PT PT02701498T patent/PT1383733E/pt unknown
- 2002-03-04 CN CNB028085124A patent/CN1321107C/zh not_active Expired - Fee Related
- 2002-03-04 BR BR0208992-0A patent/BR0208992A/pt not_active IP Right Cessation
- 2002-03-04 KR KR1020037013659A patent/KR100551183B1/ko not_active IP Right Cessation
- 2002-03-04 WO PCT/IB2002/000660 patent/WO2002085843A2/en active IP Right Grant
- 2002-03-04 YU YU78303A patent/YU78303A/sh unknown
- 2002-03-04 DK DK02701498T patent/DK1383733T3/da active
- 2002-03-04 CZ CZ20032814A patent/CZ20032814A3/cs unknown
- 2002-03-04 RU RU2003130751/04A patent/RU2282619C9/ru not_active IP Right Cessation
- 2002-03-04 JP JP2002583371A patent/JP2004527545A/ja active Pending
- 2002-03-04 EP EP02701498A patent/EP1383733B1/en not_active Expired - Lifetime
- 2002-03-04 AU AU2002234836A patent/AU2002234836B2/en not_active Ceased
- 2002-03-04 DE DE60225433T patent/DE60225433T2/de not_active Expired - Fee Related
- 2002-03-04 AT AT02701498T patent/ATE388135T1/de not_active IP Right Cessation
- 2002-03-04 HU HU0303811A patent/HUP0303811A3/hu unknown
- 2002-03-04 PL PL02366657A patent/PL366657A1/xx not_active Application Discontinuation
- 2002-03-04 IL IL15788102A patent/IL157881A0/xx unknown
- 2002-04-15 TW TW091107632A patent/TWI244472B/zh not_active IP Right Cessation
- 2002-04-17 US US10/124,135 patent/US7091372B2/en not_active Expired - Fee Related
- 2002-04-18 AR ARP020101424A patent/AR035957A1/es active IP Right Grant
-
2003
- 2003-09-15 ZA ZA200307205A patent/ZA200307205B/en unknown
-
2004
- 2004-03-17 AR ARP040100885A patent/AR043636A2/es active IP Right Grant
- 2004-07-14 HK HK04105132A patent/HK1062170A1/xx not_active IP Right Cessation
-
2005
- 2005-11-23 US US11/286,055 patent/US7186870B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1383733T3 (da) | Fremgangsmåde til fremstilling af 1,3-substituerede indener og aryl-sammenföjede azapolycykliske forbindelser | |
DK2380568T3 (da) | Fremgangsmåde til fremstilling og krystallisation af reduceret coenzyme Q 10 | |
NO20012158D0 (no) | Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav | |
DK1180518T3 (da) | 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
DK1044969T3 (da) | Fremgangsmåde og mellemprodukter til fremstilling af anti-cancer forbindelser | |
DK1296935T3 (da) | Fremgangsmåde til fremstilling af substituerede octanoylamider | |
NO20042147L (no) | Heterocykliske forbindelser og fremgangsmater for anvendelse derav | |
NO20030443D0 (no) | Fremgangsmåte for fremstilling av funksjonelle proteindomener | |
DK1181272T3 (da) | Fremgangsmåde til fremstilling af rent citalopram | |
DK1181713T3 (da) | Fremgangsmåde til fremstilling af rent citalopram | |
NO20004896D0 (no) | Pyridazinonhydrokloridforbindelse og fremgangsmÕte for fremstilling derav | |
EE200300400A (et) | Pürimidiiniühendid, nende valmistamismeetod ning kasutamine | |
NO20035738D0 (no) | Kontrollert frigivelsessammensetning og metode for å produsere det samme | |
NO20032332D0 (no) | Benzodiazepinderivatforbindelser, fremgangsmåte til fremstilling og anvendelse derav | |
DK1380121T3 (da) | Fremgangsmåde til fremstilling af oxazolidinoner | |
DK1279665T3 (da) | Fremgangsmåde til fremstilling af perindopril, analoge forbindelser og salte heraf ved anvendelse af 2,5-dioxo-oxazolidin-mellemforbindelser | |
DK1147075T3 (da) | Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid | |
DK1328538T3 (da) | Fremgangsmåde og mellemprodukter til fremstilling af 7-substituerede antiöstrogener | |
NO20033433L (no) | Fremgangsmåte for fremstilling av 2-(2-pyridylmetyl)sulfinyl- 1H-benzimidasol | |
DK1138677T3 (da) | Fremgangsmåde til fremstilling af 11-amino-3-chlor-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thiazepin og anvendelse til syntese af tianeptin | |
DK1399424T3 (da) | Fremgangsmåde til fremstilling af 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid og 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid | |
DK1456229T3 (da) | Fremgangsmåe til fremstilling af echinocandin-derivater | |
NO20013735L (no) | Fremgangsmåte til fremstilling av di-iso-butaner, di-iso- butener og di-n-butener fra feltbutaner | |
DK1373232T3 (da) | Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner | |
DK0965589T3 (da) | Fremgangsmåde og mellemprodukter til fremstillingen af pyridin-2,3-dicarboxylatforbindelser |